Ozempic: The Impact on Weight Loss and the Pharmaceutical Industry

This chapter explores the development of ozempic as a drug for type two diabetes with the additional benefit of appetite and weight loss. It discusses the financial success of the pharmaceutical company Novo Nordisk, the implications of ozempic for culture and celebrities, and questions the assumption that being fat is unhealthy.